187.22
Iqvia Holdings Inc stock is traded at $187.22, with a volume of 946.29K.
It is down -1.82% in the last 24 hours and up +0.70% over the past month.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$190.69
Open:
$188.38
24h Volume:
946.29K
Relative Volume:
0.54
Market Cap:
$31.83B
Revenue:
$15.70B
Net Income/Loss:
$1.24B
P/E Ratio:
27.09
EPS:
6.91
Net Cash Flow:
$2.01B
1W Performance:
-0.25%
1M Performance:
+0.70%
6M Performance:
+0.97%
1Y Performance:
-21.47%
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
![]()
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
Dec-20-24 | Initiated | Stephens | Overweight |
Oct-14-24 | Initiated | Redburn Atlantic | Buy |
Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
Jun-06-24 | Initiated | Goldman | Buy |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
Feb-13-24 | Initiated | BTIG Research | Buy |
Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Sep-06-23 | Initiated | HSBC Securities | Buy |
Mar-17-23 | Initiated | Truist | Buy |
Dec-06-22 | Initiated | Cowen | Outperform |
Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
Aug-25-22 | Initiated | Credit Suisse | Outperform |
Jul-15-22 | Initiated | SVB Leerink | Outperform |
May-24-22 | Initiated | Guggenheim | Buy |
Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Mar-03-21 | Initiated | Barclays | Overweight |
Jul-07-20 | Initiated | Stephens | Equal-Weight |
Mar-02-20 | Initiated | Deutsche Bank | Buy |
Jan-08-20 | Initiated | Wells Fargo | Overweight |
Jan-07-20 | Initiated | Citigroup | Buy |
Dec-13-19 | Upgrade | CFRA | Sell → Hold |
Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
May-28-19 | Initiated | SVB Leerink | Outperform |
Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
Oct-09-18 | Initiated | UBS | Buy |
Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
Jul-25-18 | Reiterated | Stifel | Buy |
Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
Dynamic Technology Lab Private Ltd Takes Position in IQVIA Holdings Inc. $IQV - MarketBeat
Adage Capital Partners GP L.L.C. Has $12.73 Million Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. $IQV Shares Sold by Teza Capital Management LLC - MarketBeat
Petrus Trust Company LTA Acquires 1,848 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Aristeia Capital L.L.C. Acquires Shares of 2,518 IQVIA Holdings Inc. $IQV - MarketBeat
Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching - uk.finance.yahoo.com
United Services Automobile Association Takes Position in IQVIA Holdings Inc. $IQV - MarketBeat
NewEdge Advisors LLC Purchases 2,626 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
NFJ Investment Group LLC Decreases Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
Why IQVIA (IQV) Stock Is Up Today - Yahoo Finance
IQVIA (NYSE:IQV) Raised to Buy at Jefferies Financial Group - MarketBeat
Semmax Financial Advisors Inc. Has $3.35 Million Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
How Is IQVIA Holdings' Stock Performance Compared to Other Health Tech Stocks? - inkl
Focus Partners Advisor Solutions LLC Invests $365,000 in IQVIA Holdings Inc. $IQV - MarketBeat
Vident Advisory LLC Buys 1,694 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. $IQV Stock Holdings Increased by Punch & Associates Investment Management Inc. - MarketBeat
IQVIA: A Positive Long-Term Outlook Despite Trump Legislation - Seeking Alpha
AQR Capital Management LLC Acquires 248,353 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. $IQV Position Reduced by EFG Asset Management North America Corp. - MarketBeat
Royal Bank of Canada Sells 79,539 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Invenomic Capital Management LP Has $15.53 Million Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Amundi Has $146.66 Million Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Iqvia launches ai-powered clinical trial financial suite for integrated management - MarketScreener
Iqvia Announces Launch of Clinical Trial Financial Suite, A Next-Generation Platform for Integrated Financial Management - MarketScreener
IQVIA Holdings Inc. (IQV) and Flagship Pioneering Partner to Accelerate Growth of Breakthrough Life Sciences Companies - Insider Monkey
Edmond DE Rothschild Holding S.A. Reduces Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
Nippon Life Global Investors Americas Inc. Raises Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Panagora Asset Management Inc. Has $1.34 Million Position in IQVIA Holdings Inc. $IQV - MarketBeat
Baird Financial Group Inc. Sells 13,125 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Copperleaf Capital LLC Has $876,000 Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Hawk Ridge Capital Management LP Takes Position in IQVIA Holdings Inc. $IQV - MarketBeat
What is the target price for IQVIA Holdings Inc. stockMarket Performance Recap & Technical Analysis for Trade Confirmation - Lancaster City Council
Iqvia Shares Rise After Jefferies Upgrade - MarketScreener
How does IQVIA Holdings Inc. score in quality rankingsJuly 2025 Reactions & Weekly High Conviction Trade Ideas - Lancaster City Council
IQV Upgraded to Buy by Jefferies, Price Target Raised to $225 | - GuruFocus
Jefferies Upgrades IQVIA Holdings to Buy From Hold, Raises Price Target to $225 From $195 - MarketScreener
Jefferies upgrades IQVIA stock to Buy on strong CRO business performance - Investing.com Canada
Federation des caisses Desjardins du Quebec Reduces Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. (NYSE:IQV) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
IQVIA Holdings Announces New CFO Appointment - MSN
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):